AI-generated summary
The authors report a flexible wearable device that combines organic light-emitting diodes, which switch between red and blue emission, with organic photodiodes for sensing. They describe using it for pulse-based physiological monitoring and for red-light and blue-light treatments, including bilirubin photodegradation, and report stable thermal and mechanical performance. The abstract describes a device-level demonstration and does not report clinical outcomes in patients.
- Who or what was studied
- unclear
- Wavelengths
- 624, 464 nm
- Limits stated in the abstract
- The abstract reports device demonstrations without stated sample sizes or clinical testing in human participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubs.acs.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 624 nm, 464 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Wavelength, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.